357 related articles for article (PubMed ID: 12887186)
21. Protection induced by commercially available live-attenuated and recombinant viral vector vaccines against infectious laryngotracheitis virus in broiler chickens.
Vagnozzi A; Zavala G; Riblet SM; Mundt A; García M
Avian Pathol; 2012; 41(1):21-31. PubMed ID: 22845318
[TBL] [Abstract][Full Text] [Related]
22. Pathogenicity and growth characteristics of selected infectious laryngotracheitis virus strains from the United States.
Oldoni I; Rodríguez-Avila A; Riblet SM; Zavala G; García M
Avian Pathol; 2009 Feb; 38(1):47-53. PubMed ID: 19156579
[TBL] [Abstract][Full Text] [Related]
23. Immune responses to infectious laryngotracheitis virus.
Coppo MJ; Hartley CA; Devlin JM
Dev Comp Immunol; 2013 Nov; 41(3):454-62. PubMed ID: 23567343
[TBL] [Abstract][Full Text] [Related]
24. The route of inoculation dictates the replication patterns of the infectious laryngotracheitis virus (ILTV) pathogenic strain and chicken embryo origin (CEO) vaccine.
Beltrán G; Williams SM; Zavala G; Guy JS; García M
Avian Pathol; 2017 Dec; 46(6):585-593. PubMed ID: 28532159
[TBL] [Abstract][Full Text] [Related]
25. Protection against infectious laryngotracheitis by in ovo vaccination with commercially available viral vector recombinant vaccines.
Johnson DI; Vagnozzi A; Dorea F; Riblet SM; Mundt A; Zavala G; García M
Avian Dis; 2010 Dec; 54(4):1251-9. PubMed ID: 21313847
[TBL] [Abstract][Full Text] [Related]
26. Glycoprotein G deficient infectious laryngotracheitis virus is a candidate attenuated vaccine.
Devlin JM; Browning GF; Hartley CA; Gilkerson JR
Vaccine; 2007 May; 25(18):3561-6. PubMed ID: 17316926
[TBL] [Abstract][Full Text] [Related]
27. Development of an enzyme-linked immunosorbent assay to detect chicken serum antibody to glycoprotein G of infectious laryngotracheitis virus.
Shil NK; Markham PF; Noormohammadi AH; O'Rourke D; Devlin JM
Avian Dis; 2012 Sep; 56(3):509-15. PubMed ID: 23050467
[TBL] [Abstract][Full Text] [Related]
28. Attenuation and Protection Efficacy of a Recombinant Infectious Laryngotracheitis Virus (ILTV) Depleted of Open Reading Frame C (ΔORFC) when Delivered in ovo.
Schneiders GH; Riblet SM; García M
Avian Dis; 2018 Jun; 62(2):143-151. PubMed ID: 29944395
[TBL] [Abstract][Full Text] [Related]
29. Immune Responses in the Eye-Associated Lymphoid Tissues of Chickens after Ocular Inoculation with Vaccine and Virulent Strains of the Respiratory Infectious Laryngotracheitis Virus (ILTV).
Beltrán G; Hurley DJ; Gogal RM; Sharif S; Read LR; Williams SM; Jerry CF; Maekawa DA; García M
Viruses; 2019 Jul; 11(7):. PubMed ID: 31295877
[TBL] [Abstract][Full Text] [Related]
30. Rapid detection and characterization from field cases of infectious laryngotracheitis virus by real-time polymerase chain reaction and restriction fragment length polymorphism.
Creelan JL; Calvert VM; Graham DA; McCullough SJ
Avian Pathol; 2006 Apr; 35(2):173-9. PubMed ID: 16595312
[TBL] [Abstract][Full Text] [Related]
31. Replication and transmission of live attenuated infectious laryngotracheitis virus (ILTV) vaccines.
Rodríguez-Avila A; Oldoni I; Riblet S; García M
Avian Dis; 2007 Dec; 51(4):905-11. PubMed ID: 18251401
[TBL] [Abstract][Full Text] [Related]
32. Protection of chickens from Newcastle disease and infectious laryngotracheitis with a recombinant fowlpox virus co-expressing the F, HN genes of Newcastle disease virus and gB gene of infectious laryngotracheitis virus.
Sun HL; Wang YF; Tong GZ; Zhang PJ; Miao DY; Zhi HD; Wang M; Wang M
Avian Dis; 2008 Mar; 52(1):111-7. PubMed ID: 18459306
[TBL] [Abstract][Full Text] [Related]
33. Comparison of the safety and protective efficacy of vaccination with glycoprotein-G-deficient infectious laryngotracheitis virus delivered via eye-drop, drinking water or aerosol.
Devlin JM; Browning GF; Gilkerson JR; Fenton SP; Hartley CA
Avian Pathol; 2008 Feb; 37(1):83-8. PubMed ID: 18202954
[TBL] [Abstract][Full Text] [Related]
34. Mild infectious laryngotracheitis in broilers in the southeast.
Sellers HS; García M; Glisson JR; Brown TP; Sander JS; Guy JS
Avian Dis; 2004; 48(2):430-6. PubMed ID: 15283433
[TBL] [Abstract][Full Text] [Related]
35. Safety and efficacy of a turkey herpesvirus vector laryngotracheitis vaccine for chickens.
Esaki M; Noland L; Eddins T; Godoy A; Saeki S; Saitoh S; Yasuda A; Dorsey KM
Avian Dis; 2013 Jun; 57(2):192-8. PubMed ID: 24689173
[TBL] [Abstract][Full Text] [Related]
36. Comparison of the replication and transmissibility of an infectious laryngotracheitis virus vaccine delivered via eye-drop or drinking-water.
Coppo MJ; Devlin JM; Noormohammadi AH
Avian Pathol; 2012; 41(1):99-106. PubMed ID: 22845327
[TBL] [Abstract][Full Text] [Related]
37. Characterization of infectious laryngotracheitis virus (ILTV) isolates from commercial poultry by polymerase chain reaction and restriction fragment length polymorphism (PCR-RFLP).
Oldoni I; Rodríguez-Avila A; Riblet S; García M
Avian Dis; 2008 Mar; 52(1):59-63. PubMed ID: 18459297
[TBL] [Abstract][Full Text] [Related]
38. Analysis of Korean strains of infectious laryngotracheitis virus by nucleotide sequences and restriction fragment length polymorphism.
Han MG; Kim SJ
Vet Microbiol; 2001 Dec; 83(4):321-31. PubMed ID: 11600266
[TBL] [Abstract][Full Text] [Related]
39. Studies on the live-virus vaccine against infectious laryngotracheitis of chickens. II. Evaluation of the tissue-culture-modified strain C7 in laboratory and field trials.
Izuchi T; Hasegawa A; Miyamoto T
Avian Dis; 1984; 28(2):323-30. PubMed ID: 6331361
[TBL] [Abstract][Full Text] [Related]
40. Pathogenic and Transmission Potential of Wildtype and Chicken Embryo Origin (CEO) Vaccine Revertant Infectious Laryngotracheitis Virus.
Perez-Contreras A; Barboza-Solis C; Najimudeen SM; Checkley S; Meer FV; Joseph T; King R; Ravi M; Peters D; Fonseca K; Gagnon CA; Ojkic D; Abdul-Careem MF
Viruses; 2021 Mar; 13(4):. PubMed ID: 33805117
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
